Skip to main content
Charles Powell, MD, Pulmonology, New York, NY, Mount Sinai Beth Israel

CharlesAndrewPowellMDFCCP

Pulmonology • New York, NY

Asthma & COPD, Critical Care Medicine, Interstitial Lung Diseases, Thoracic Oncology

Professor of Medicine - Chief, Division of Pulmonary, Critical Care and Sleep Medicine,

Join to view full profile

Dr. Powell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Powell's full profile

Already have an account?

  • Office

    Icahn School of Medicine at Mount Sinai
    1468 Madison Avenue, Annenberg 5-20
    New York, NY 10029
    Phone+1 212-241-4280
    Fax+1 212-876-5519
  • Is this information wrong?

Summary

  • Here in the Division of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai, the last few years have been extraordinary. In 2014 we opened the Mount Sinai-National Jewish Health Respiratory Institute, http://nationaljewish.mountsinai.org, and created a model for delivering patient centered, multidisciplinary, state-of-the-art care for patients with simple and complex respiratory diseases, which also includes physicians from Gastroenterology, Cardiology and Rheumatology. Of particular note for you, for out-of-town referrals, we provide comprehensive multi-day visits for the evaluation and treatment of undiagnosed respiratory diseases.
    We also have also the largest sarcoidosis program in the northeast and a long tradition of sarcoidosis research and treatment. Adam Morgenthau, MD, Director of the Sarcoidosis Clinic at Mount Sinai, sees approximately 100 patients with sarcoidosis a month and has tremendous experience in diagnosis and management of sarcoidosis given such an extensive patient base.
    Our Lung Cancer Research Program has identified key molecular pathways of adenocarcinoma from indolent tumor to metastatic tumor and this has become increasingly important as efforts to detect early stage lung cancers begins to pay off. Our pioneering screening program run by Claudia Henschke, MD, PhD, Professor of Radiology, has shown that CT scans can find 85 percent of lung cancers in their earliest, most treatable, stages and with greater accuracy. This screening program has now been implemented internationally as the IELCAP consortium.
    At Mount Sinai we are one of only two sites in the city for a new NIH multi-center trial (PETAL) for acute lung injury. We hope that these studies and the close collaborative relationship with Emergency Medicine within the trials will identify new opportunities for the prevention and treatment of adult respiratory distress syndrome.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1998
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Chief Residency, Internal Medicine, 1992 - 1993
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1989 - 1992
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 1991 - 2026
  • PA State Medical License
    PA State Medical License 2020 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Member, President Elect 2018 Fleischner Society
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Risk for ILD/Pneumonitis Examined for Trastuzumab Deruxtecan
    Risk for ILD/Pneumonitis Examined for Trastuzumab DeruxtecanAugust 22nd, 2022
  • Lung Adverse Effects in Patients Taking Trastuzumab Deruxtecan
    Lung Adverse Effects in Patients Taking Trastuzumab DeruxtecanAugust 18th, 2022
  • Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
    Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer TherapyApril 5th, 2022
  • Join now to see all

Grant Support

  • Lung Adenocarcinoma Invasion GenomicsNational Cancer Institute (NCI)2013–Present
  • Lung Epithelial-Mesenchymal Interactions In Adenocarcinoma InvasionNational Cancer Institute2011
  • Lung Epithelial-Mesenchymal Interactions In Adenocarcinoma InvasionNational Cancer Institute2007–2011
  • Susceptibility To Molecular Alteration: Epithelial CellsNational Institute Of Environmental Health Sciences2000–2003
  • Molecular Alterations In Epithelial Cells Of SmokersNational Center For Research Resources2000–2002
  • Susceptibility To Molecular Alteration--Epithelial CellsNational Institute Of Environmental Health Sciences1999

Committees

  • member, American Thoracic Society Planning and Evaluation Committee 2015 - Present
  • member, American Thoracic Society Program Review Subcommittee 2015 - Present

Professional Memberships

Hospital Affiliations

Dr. Charles Powell, Dr. Charles Powell, MD, Dr. C Powell, Dr. Charles Andrew Powell